Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001470831-25-000317
Filing Date
2025-11-14
Accepted
2025-11-14 16:50:41
Documents
4
Period of Report
2025-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1763157038.html 4  
1 FORM 4 wk-form4_1763157038.xml 4 7241
2 EX-24 hannahvalentine.htm EX-24 5090
3 hannahvalentine001.jpg GRAPHIC 249980
4 hannahvalentine002.jpg GRAPHIC 91496
  Complete submission text file 0001470831-25-000317.txt   484332
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1305 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address
Valantine Hannah (Reporting) CIK: 0001855608 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 251487726